IL157216A0 - Crystalline forms of pyrimidine nucleoside derivatives and pharmaceutical compositions containing the same - Google Patents

Crystalline forms of pyrimidine nucleoside derivatives and pharmaceutical compositions containing the same

Info

Publication number: IL157216A0
Authority: IL; Israel
Prior art keywords: crystalline forms; same; pharmaceutical compositions; pyrimidine nucleoside; compositions containing
Prior art date: 2001-02-09

Application number

IL15721602A

Other languages

English (en)

Original Assignee

Sankyo Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-09

Filing date

2002-02-06

Publication date

2004-02-19

2002-02-06 Application filed by Sankyo Co filed Critical Sankyo Co

2004-02-19 Publication of IL157216A0 publication Critical patent/IL157216A0/xx

Links

150000003833 nucleoside derivatives Chemical class 0.000 title abstract 2
239000002718 pyrimidine nucleoside Substances 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
230000000259 anti-tumor effect Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Biotechnology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Enzymes And Modification Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Plural Heterocyclic Compounds (AREA)

IL15721602A 2001-02-09 2002-02-06 Crystalline forms of pyrimidine nucleoside derivatives and pharmaceutical compositions containing the same IL157216A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2001033128		2001-02-09
PCT/JP2002/000986 WO2002064609A1 (en)	2001-02-09	2002-02-06	Crystal of pyrimidine nucleoside derivative

Publications (1)

Publication Number	Publication Date
IL157216A0 true IL157216A0 (en)	2004-02-19

Family

ID=18896929

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL15721602A IL157216A0 (en)	2001-02-09	2002-02-06	Crystalline forms of pyrimidine nucleoside derivatives and pharmaceutical compositions containing the same
IL157216A IL157216A (en)	2001-02-09	2003-08-04	Crystalline forms of nucleoside pyrimidine history and pharmaceutical preparations containing them

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL157216A IL157216A (en)	2001-02-09	2003-08-04	Crystalline forms of nucleoside pyrimidine history and pharmaceutical preparations containing them

Country Status (21)

Country	Link
EP (1)	EP1364959B1 (cs)
JP (2)	JP3748536B2 (cs)
KR (1)	KR100679904B1 (cs)
CN (1)	CN100408591C (cs)
AT (1)	ATE361929T1 (cs)
AU (1)	AU2002230164B2 (cs)
BR (2)	BRPI0207102A8 (cs)
CA (1)	CA2437994C (cs)
CY (1)	CY1106685T1 (cs)
CZ (1)	CZ303241B6 (cs)
DE (1)	DE60220024T2 (cs)
DK (1)	DK1364959T3 (cs)
ES (1)	ES2286237T3 (cs)
HU (1)	HU229294B1 (cs)
IL (2)	IL157216A0 (cs)
MX (1)	MXPA03007123A (cs)
NZ (1)	NZ527393A (cs)
PT (1)	PT1364959E (cs)
RU (1)	RU2256666C2 (cs)
WO (1)	WO2002064609A1 (cs)
ZA (1)	ZA200306121B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2081419B1 (en)	1999-09-02	2013-08-07	Ibiden Co., Ltd.	Printed circuit board and method of manufacturing printed circuit board
CN101232776B (zh)	1999-09-02	2011-04-20	揖斐电株式会社	印刷布线板
GB0526419D0 (en)	2005-12-23	2006-02-08	Cyclacel Ltd	Formulation
GB0625283D0 (en)	2006-12-19	2007-01-24	Cyclacel Ltd	Combination
JP5066737B2 (ja) *	2007-04-06	2012-11-07	大鵬薬品工業株式会社	シチジン誘導体を含有する持続静脈内投与用抗腫瘍剤
US8124593B2 (en)	2007-11-05	2012-02-28	Cyclacel Limited	Methods of treatment using sapacitabine
GB0808357D0 (en) *	2008-05-08	2008-06-18	Cyclacel Ltd	Process
PL2307002T3 (pl)	2008-06-09	2013-05-31	Cyclacel Ltd	Kombinacje sapacytabiny lub cndac z inhibitorami metylotransferazy dna, takimi jak decytabina i prokaina
PL2696878T3 (pl)	2011-04-14	2020-01-31	Cyclacel Limited	Schemat dawkowania dla sapacytabiny i decytabiny w kombinacji do leczenia ostrej białaczki szpikowej
ES2880109T3 (es)	2012-03-15	2021-11-23	Celgene Car Llc	Formas sólidas de un inhibidor de la cinasa del receptor del factor de crecimiento epidérmico
ES2963057T3 (es) *	2015-03-09	2024-03-25	Grace W R & Co	Forma cristalina de ribósido de nicotinamida
EP3727400A4 (en)	2017-12-22	2021-10-20	Elysium Health, Inc.	CRYSTALLINE FORMS OF NICOTINAMIDE RIBOSIDE CHLORIDE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2559917B2 (ja) *	1990-06-15	1996-12-04	三共株式会社	ピリミジンヌクレオシド誘導体
FI105556B (fi) *	1991-09-30	2000-09-15	Sankyo Co	Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta

2002
- 2002-02-04 JP JP2002026232A patent/JP3748536B2/ja not_active Expired - Lifetime
- 2002-02-06 CN CNB028079337A patent/CN100408591C/zh not_active Expired - Lifetime
- 2002-02-06 EP EP02711347A patent/EP1364959B1/en not_active Expired - Lifetime
- 2002-02-06 KR KR1020037010308A patent/KR100679904B1/ko not_active Expired - Lifetime
- 2002-02-06 CZ CZ20032111A patent/CZ303241B6/cs not_active IP Right Cessation
- 2002-02-06 DK DK02711347T patent/DK1364959T3/da active
- 2002-02-06 AU AU2002230164A patent/AU2002230164B2/en not_active Expired
- 2002-02-06 PT PT02711347T patent/PT1364959E/pt unknown
- 2002-02-06 BR BRPI0207102A patent/BRPI0207102A8/pt unknown
- 2002-02-06 IL IL15721602A patent/IL157216A0/xx active IP Right Grant
- 2002-02-06 MX MXPA03007123A patent/MXPA03007123A/es active IP Right Grant
- 2002-02-06 WO PCT/JP2002/000986 patent/WO2002064609A1/ja not_active Ceased
- 2002-02-06 BR BR0207102-9A patent/BR0207102A/pt not_active Application Discontinuation
- 2002-02-06 NZ NZ527393A patent/NZ527393A/en not_active IP Right Cessation
- 2002-02-06 HU HU0303159A patent/HU229294B1/hu unknown
- 2002-02-06 DE DE60220024T patent/DE60220024T2/de not_active Expired - Lifetime
- 2002-02-06 AT AT02711347T patent/ATE361929T1/de active
- 2002-02-06 ES ES02711347T patent/ES2286237T3/es not_active Expired - Lifetime
- 2002-02-06 CA CA2437994A patent/CA2437994C/en not_active Expired - Lifetime
- 2002-02-06 RU RU2003124648/04A patent/RU2256666C2/ru active
2003
- 2003-08-04 IL IL157216A patent/IL157216A/en unknown
- 2003-08-07 ZA ZA2003/06121A patent/ZA200306121B/en unknown
2005
- 2005-08-09 JP JP2005230800A patent/JP4356998B2/ja not_active Expired - Lifetime
2007
- 2007-07-02 CY CY20071100860T patent/CY1106685T1/el unknown

Also Published As

Publication number	Publication date
HUP0303159A3 (en)	2007-06-28
AU2002230164B2 (en)	2005-04-07
HUP0303159A2 (hu)	2003-12-29
BRPI0207102A8 (pt)	2018-02-27
KR100679904B1 (ko)	2007-02-07
CA2437994C (en)	2011-05-17
WO2002064609A1 (en)	2002-08-22
CZ20032111A3 (cs)	2003-12-17
CN1501939A (zh)	2004-06-02
KR20030081424A (ko)	2003-10-17
ES2286237T3 (es)	2007-12-01
CY1106685T1 (el)	2012-05-23
HU229294B1 (en)	2013-10-28
EP1364959B1 (en)	2007-05-09
ZA200306121B (en)	2005-01-26
CA2437994A1 (en)	2002-08-22
DK1364959T3 (da)	2007-06-04
EP1364959A1 (en)	2003-11-26
NZ527393A (en)	2004-07-30
PT1364959E (pt)	2007-07-23
RU2256666C2 (ru)	2005-07-20
ATE361929T1 (de)	2007-06-15
BR0207102A (pt)	2004-01-27
JP4356998B2 (ja)	2009-11-04
DE60220024T2 (de)	2007-11-22
JP2006008699A (ja)	2006-01-12
EP1364959A4 (en)	2004-03-24
CN100408591C (zh)	2008-08-06
IL157216A (en)	2008-03-20
MXPA03007123A (es)	2003-11-18
JP2002308895A (ja)	2002-10-23
JP3748536B2 (ja)	2006-02-22
RU2003124648A (ru)	2005-02-27
DE60220024D1 (en)	2007-06-21
CZ303241B6 (cs)	2012-06-13

Similar Documents

Publication	Publication Date	Title
ES2175624T3 (es)	2002-11-16	Derivados de pirazolo(4,3-d)pirimidina y composiciones farmaceuticas que los contienen.
IL144461A0 (en)	2002-05-23	Quinoline and quinazoline derivatives and pharmaceutical compositions containing them
BE2018C008I2 (cs)	2021-02-04
IL135536A0 (en)	2001-05-20	Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same
IL159418A0 (en)	2004-06-01	Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
DK1442024T3 (da)	2008-06-30	Aminobenzamidderivater som glycogensystasekinase 3 beta-inhibitorer
HK1053831A1 (zh)	2003-11-07	作为治疗药物的激酶抑制剂
IS8825A (is)	2009-06-02	Ný kristölluð og myndlaus form af tríasól (4,5-D) pýrimídínefnasambandi
MXPA04003886A (es)	2004-07-08	Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
YU57603A (sh)	2006-08-17	Inhibitori fosfodiesteraze 4
UA83091C2 (en)	2008-06-10	Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors
CY1106685T1 (el)	2012-05-23	Κρυσταλλος παραγωγου πυριμιδινο νουκλεοζιτη
NO301543B1 (no)	1997-11-10	2-£4-(kinazolinylmetylamino)benzamido\|-4-(tetrazolyl)smörsyrederivater med anti-tumor-aktivitet
GB0127903D0 (en)	2002-01-16	Improvements relating to organic compounds
MXPA02004440A (es)	2004-09-10	Derivados de pirrol como inhibidores de la fosfodiesterasa vii.
IL136100A (en)	2005-05-17	Biphenylamidine derivatives and pharmaceutical compositions containing the same
CA2452036A1 (en)	2003-01-09	6-'2-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity
GB0215392D0 (en)	2002-08-14	Chemical compounds
WO2002062798A3 (en)	2002-12-05	Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
MY129094A (en)	2007-03-30	Condensed polycyclic compounds
NO994135D0 (no)	1999-08-26	Kinoksalindioner
WO2003086412A3 (fr)	2004-04-01	Derives poly-phosphonates pour compositions dentifrices
EP1057829A4 (en)	1999-12-10	Condensed pyrimidine derivatives and pharmaceutical compositions containing them
IL166313A0 (en)	2006-01-15	Indoline derivatives and pharmaceutical compositions containing the same
EP1466900A4 (en)	2005-07-20	DERIVATIVES OF VITAMIN D-DOUBLE SUBSTITUTION

Legal Events

Date	Code	Title	Description
2008-11-03	FF	Patent granted
2008-11-27	KB	Patent renewed